Navigation Links
Intercell AG Announces Q3 2010 Results and Updates on R&D Progress and Management
Date:11/9/2010

VIENNA, Nov. 9, 2010 /PRNewswire-FirstCall/ -- Today, Intercell AG (VSE: ICLL) announced its financial results for the third quarter of 2010 and presented an update on the Company's key R&D programs as well as changes to the Management Board.

Financial Results

  • IXIARO and JESPECT sales revenues continue showing significant year-on-year growth – sales revenues totaled EUR 9.4m in the 9 months ended September 30, 2010, compared to EUR 5.6m in the same period of the previous year.
  • Intercell's aggregate revenues decreased by 28.4% from EUR 29.5m in the 9 months ended September 30, 2009 to EUR 21.1m in the same period of 2010.
  • Net loss for the first nine months of 2010 increased to EUR 50.9m mainly driven by increased R&D expenses for late stage development programs and non-cash currency effects.
  • Solid cash position with EUR 107.1m.
  • Outlook full year 2010: Net loss for the full year 2010 expected to reach approximately EUR 40.0m, at the high end of previously communicated range, and this assumes positive outcome of upcoming milestone events.

  • Key Financial FiguresEUR in thousands

    3 months ended

    9 months ended

    Year endedSept 30,
    2010Sept 30,
    2009

    Sept 30,
    2010Sept 30,
    2009

    Dec 31,
    2009Revenues

    6,7049,159

    21,11829,480

    61,681Net profit/(loss)

    (27,844)(14,671)

    (50,892)(25,925)

    (18,375)Net operating cash flow

    (22,724)(14,753)

    (49,218)(43,322)

    (25,995)Cash and available-for-sale financial assets, end of period

    107,141139,746

    107,141139,746

    180,019IXIARO®/JESPECT®Intercell reports that the positive trend of increasing sales of IXIARO/JESPECT seen in Q2 2010 continued in Q3. Intercell's product is the only vaccine against Japanese Encephalitis licensed in Europe. It is manufactured for, and supplied into, the U.S., EU and Canada and the only
    '/>"/>

    SOURCE Intercell AG
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Intercell Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study for Certain Hospital-Acquired Infections
    2. Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C
    3. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
    4. Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer
    5. Intercell Acquires Antibody Technology Platform to Further Exploit Its Capabilities to Combat Infectious Diseases
    6. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
    7. Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
    8. Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers Diarrhea Vaccine Study
    9. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
    10. Favourable Six Months Follow-Up Results From Intercells Phase II Therapeutic Hepatitis C Program
    11. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/11/2014)... , July 11, 2014 Research and ... "Global and Chinese Medical X-ray Film Industry Report 2014" ... http://photos.prnewswire.com/prnh/20130307/600769 Global And Chinese Medical ... in-depth study on the current state of the Global ... Chinese situation. The report provides a basic overview ...
    (Date:7/11/2014)... July 11, 2014  Kindred Hospital Houston Northwest, ... the opening of its new outpatient wound healing ... to people with chronic, hard to heal wounds. ... lead to amputation, lower leg wounds related to ... closure, and traumatic injury wounds which are complex ...
    (Date:7/11/2014)... ALBANY, New York , July 11, 2014 /PRNewswire/ ... published by Transparency Market Research "Endoscopy Devices Market (Endoscopes, ... Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019" the ... billion in 2012 and is expected to grow at ... reach an estimated value of USD 36.9 billion in ...
    Breaking Medicine Technology:Global and Chinese Medical X-ray Film Industry Report 2014 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6
    ... 2011 /PRNewswire-iReach/ -- In the world of veterinary ... is a 1 in 9 chance of anesthetic complications and ... cats. It is with great pride that LEI Medical ... history; having never had a single, equipment-related animal death reported. ...
    ... Medical Inc., a leader in developing minimally invasive medical ... tissue from the gastrointestinal tract, announces today that they ... Covidien.  Covidien is a leading global provider of healthcare ... Covidien will acquire all of the ...
    Cached Medicine Technology:LEI Medical Emerges as an Innovator and Leads the Way in Safety 2LEI Medical Emerges as an Innovator and Leads the Way in Safety 3BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien 2BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien 3
    (Date:7/12/2014)... News) -- Burn injuries increase in the summer as people ... experts. Among those most vulnerable to these seasonal fire hazards: ... often get burned by putting their hands on the side ... burn unit at Loyola University Medical Center in Maywood, Ill., ... of ,When you play with fire, you get burned, is ...
    (Date:7/12/2014)... “After my mom’s stroke, she loss the use ... loss the use of his left side. Eating became a difficult ... help people like them enjoy eating again,” said an inventor, from ... PATRICIA CAROL HALL PLATE (P C H PLATE). , The PATRICIA ... way to eat for individuals who suffer from stroke, experience tremors ...
    (Date:7/12/2014)... With prom shopping reaching its final ... is ready to showcase its new and trendy apparels. ... evening dresses in its online shop. Additionally, it is ... these elegant gowns. According to the company’s sales manager, ... 26, 2014. , He says, “Now, worldwide clients ...
    (Date:7/12/2014)... Albany, NY (PRWEB) July 12, 2014 ... to 2020 - New and Late-Stage Four-Factor PCCs ... in-depth analysis of the critical care market in ... and Canada. The report provides an estimation of ... to 2020. It covers critical care indications that ...
    (Date:7/12/2014)... City, Utah (PRWEB) July 12, 2014 ... two types of startups, with awards being bestowed to ... emphasis spotlighted Utah’s outstanding entrepreneur community with recognition for ... a sustainable model with incoming revenue. , 25 Under ... across the state that are under 5 years old. ...
    Breaking Medicine News(10 mins):Health News:Burn Injuries More Common in Summer 2Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2
    ... , WASHINGTON, Aug. 26 Danaher Corporation ... Executive Officer, H. Lawrence Culp, Jr. will be presenting at ... on Wednesday, September 2, 2009 at 12:30 p.m. EDT. The ... the webcast will be available for one week following the ...
    ... , MCLEAN, Va., Aug. 26 MicroStrategy((R)) ... provider of business intelligence (BI) software, today announced that ... has selected MicroStrategy to improve its sales reporting and ... international pharmaceuticals company Boehringer Ingelheim. , , ...
    ... , MISSION, Kan., Aug. 26 Like ... new ways to operate cost-effectively and use tax dollars wisely. ... administration program. And effective October 2009, Kansas City-based COBRAGuard, Inc. ... , Of course, with every outsourcing situation, ...
    ... ... anti-aging . , ... -- Every morning women all across America wake up, head to the makeup mirror, and add ... is hailed by Allure magazine as one of the most influential beauty breakthroughs of the decade, ...
    ... , , NEW YORK, Aug. 26 ... applied to the government broadband stimulus fund to provide broadband access ... areas exist in all 50 states because they are not connected ... or too disperse and challenging to dig ditches and lay wires. ...
    ... , SOUTHAMPTON, Pa., Aug. 26 ... the "Company") BioMedical Systems Division, a product division in ... SRL for the delivery and installation of the first ... , Histria International is a "turn-key" ...
    Cached Medicine News:Health News:Boehringer Ingelheim's Swiss Branch Improves Sales Reporting and Efficiency with MicroStrategy Software 2Health News:Boehringer Ingelheim's Swiss Branch Improves Sales Reporting and Efficiency with MicroStrategy Software 3Health News:State of Kansas Streamlines COBRA Administration With Innovative Web-Based Solution 2Health News:5 Simple Ways to Take 10 Years Off Your Face 2Health News:5 Simple Ways to Take 10 Years Off Your Face 3Health News:5 Simple Ways to Take 10 Years Off Your Face 4Health News:01 Data Center Applied to Provide Broadband Access to Healthcare Facilities in Unserved Areas 2Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces First BARA-MED(R) Monoplace Hyperbaric Chamber Sale in Romania 2Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces First BARA-MED(R) Monoplace Hyperbaric Chamber Sale in Romania 3Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces First BARA-MED(R) Monoplace Hyperbaric Chamber Sale in Romania 4
    For implantation in proximal interphalangeal joints of the lateral toes to correct deformity associated with degenerative or rheumatoid arthritis....
    Part of the GraFix® Cruciate Reconstruction System, which is designed to facilitate arthroscopic anterior cruciate ligament reconstructions....
    ... a new standard in the field of hammertoe ... Made of medical grade silicone, these durable and ... high level of flexibility while maintaining correct toe ... in varying stiffnesses. Lengths are determined by the ...
    ... Kinetik Great Toe Implant (KGTI) system offers ... of the first MPJ. The implant system ... of motion. , ,The KGTI is the ... metatarsophalangeal joint (MPJ) on the market today. ...
    Medicine Products: